Article
Lilly says experimental Alzheimer's drug reduces amyloid in small study
Rating:
0.0
Views:
64
Likes:
1
Library:
1
Eli Lilly and Co on Friday said early data from the first human study of its next-generation Alzheimer's treatment showed that it lowered levels of toxic amyloid plaques in the brains of people in the earliest stages of the mind-wasting disease.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value